Decision approves kidney cancer drug for NHS use A new draft guidance has recommended everolimus for treating some people with advanced kidney cancer, a drug previously only available through the Cancer Drugs Fund (CDF). The committee looked at new evidence and a price discount submitted by the drugs company, and was able to approve the…
